Hashtag
The Times Real Estate

Essential Safety Equipment for Roofing Work

Roofing is one of the most dangerous trades, with falls being a leading cause of workplace injuries.  Having the right roofing sa...

How to Choose the Right Forex Trading Platform

Every trader requires a trustworthy platform with real-time data, flawless execution, and the necessary tools to examine the ma...

Transformative Beauty Experiences in the Heart of Neutral Bay

This beauty parlour is a refuge of luxury and peace tucked away in the quaint area of Neutral Bay. Skilled beauticians offer c...

Why Annual House Inspections are Crucial for Maintaining Property Value

A home is one of the most valuable assets you'll ever own, but keeping it in top condition requires ongoing care. What may seem ...

Electronic Logbooks vs. Paper Logbooks: Why Digital Solutions Are the Future

Every business needs accurate tracking and documentation for daily operations, compliance, and equipment maintenance; without it...

The Importance of Having a Defibrillator in Public Spaces

Life is uncertain! It is almost impossible to be 100% sure of the future, anything can happen to anyone at any time. However, i...

The Aptegra CHO genetic stability assay leverages whole genome sequencing and bioinformatics to significantly accelerate biosafety testing for clients and therefore, their move into commercial production.

"Driving innovation in biosafety testing is essential to bringing new therapies to patients faster," said Benjamin Hein, Head of Life Science Services, Life Science business of Merck. "CHO genetic stability testing has remained relatively unchanged for many years. The Aptegra platform transforms biosafety testing with a digital solution using next-generation sequencing."

A scientist preparing samples in the next-generation sequencing laboratory at Merck’s/MilliporeSigma’s Rockville, Maryland, USA site.
A scientist preparing samples in the next-generation sequencing laboratory at Merck’s/MilliporeSigma’s Rockville, Maryland, USA site.

Currently, FDA guidance requires biotech companies to use multiple assays to address genetic stability requirements. This traditional package of assays is costly, time-consuming, and often results in data that need additional interpretation and support. The Aptegra platform addresses these pain points by replacing five different assays and four different technologies with one assay utilizing the next-generation sequencing technology platform. This approach reduces testing time by 66 percent and reduces costs by 43 percent compared to traditional methods. The platform meets all regulatory requirements for genetic stability assurance, including copy number assessment.

Merck has made significant investments over the last five years to expand its biosafety testing capabilities for clients across the globe. The company's global biosafety testing network includes sites in Shanghai, China; Singapore; Stirling and Glasgow, UK; and Rockville, MD, USA.

The Aptegra digital platform adds to a transformative portfolio of digital technologies developed by Merck. In December, Merck launched AIDDISON™, an AI-powered platform that integrates generative design with predictive synthesis planning, allowing rapid identification of promising candidates and reducing risk of late-stage failures. Additionally, Merck offers a first of its kind Bio4C® Software Suite, which combines data analytics and visualization, automation, and control software for GMP manufacturing.

All Merck press releases are distributed by e-mail at the same time they become available on the Merck website. Please go to www.merckgroup.com/subscribe to register online, change your selection or discontinue this service.
Hashtag: #Merck

The issuer is solely responsible for the content of this announcement.

Merck

Merck, a leading science and technology company, operates across life science, healthcare and electronics. Around 63,000 employees work to make a positive difference to millions of people's lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2023, Merck generated sales of € 21 billion in 65 countries.

Scientific exploration and responsible entrepreneurship have been key to Merck's technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as MilliporeSigma in life science, EMD Serono in healthcare, and EMD Electronics in electronics.

IN THE NEWS

NTT Wins Best AI Application Award - Bronze at 2024 CAHK STAR Awards

Recognized for its innovative AI-driven Smart Building Management System, transforming facility operation.

Glide Across the Water with Stand Up Paddle Boarding

Introduction is the start of anything new. It can be an introduction to a person, place, thing or idea.

ABBANK invests in Backbase to launch digital banking platform with 100% customer migration in 3 mont…

ABBANK accelerates customer-centricity for business owners through platform innovation HANOI, VIETNAM - .

Higher for longer interest rate environment continues to benefit banks’ profitability in 2024, KPMG …

Banks must stay ahead of technology development and climate risks to thrive in fast-changing HONG KONG SA.

DHL Express Hong Kong becomes the Official Partner of Kai Tak Sports Park

Both parties will collaborate to drive the growth of sports and entertainment events to the city and help.

Thai Court Orders Seizure of Over $10 Million in Assets from Ex-DSI Chief Following NACC Probe

BANGKOK, THAILAND - Media OutReach Newswire - 17 May 2024 - The National Anti-Corruption Commission (NAC.

Health & Wellness

The Importance of Having a Defibrillator in Public Spaces

Hashtag.net.au - avatar Hashtag.net.au

Life is uncertain! It is almost impossible to be 100% sure of the future, anything can happen to anyone at any time. However, in the case of Sudden Cardiac Arrests (SCA), the presence of an Automat...

Understanding Anxiety: Different Types and Treatment Options

Hashtag.net.au - avatar Hashtag.net.au

(Source) Every person experiences anxiety in some form as they face either pre-event heart palpitations before important events or constant sleep deprivation because of ongoing concerns. People exp...

How Technology Is Improving Community Support Services?

Hashtag.net.au - avatar Hashtag.net.au

(Source) Technology is literally a part of our everyday lives. Everything we do is highly dependent on technology in this day and age. The interesting part is that not just the younger generations ...